← All trials
NCT01743755
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2012
- Primary completion
- May 1, 2017
- Completion date
- May 1, 2018
- First posted
- —
- Last posted
- —
- Enrollment
- 600
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- St. Antonius Hospital, NieuwegeinLead sponsor
- Canisius-Wilhelmina HospitalOverall official - principal investigator
- Canisius-Wilhelmina HospitalCollaborator
- Onze Lieve Vrouw HospitalCollaborator
- Maastricht UniversityOverall official - principal investigator
- Maastricht UniversityCollaborator
- Onze Lieve Vrouw HospitalOverall official - principal investigator
- St. Antonius Hospital, NieuwegeinOverall official - principal investigator
- St. Antonius Hospital, NieuwegeinReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.